Lubiprostone Capsules- Solicitation closing date is extended SPE2D224R0006-0002
Closed Pre-Solicitation Posted
- Solicitation number
- SPE2D2-24-R-0006
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency (DLA) Troop Support Medical is planning to issue a solicitation for a national requirements contract for Lubiprostone Capsules (8 MCG & 24 MCG) 60 count bottles. This will be an unrestricted and fully competitive commercial item acquisition conducted under FAR Part 12. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. The contract will establish a national supply source to provide the Lubiprostone Capsules to Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through the DLA and VA prime vendor programs. The estimated annual usage will be provided in the solicitation, and interested parties should contact Keith Ryales for any questions or comments.
This acquisition has no set-aside designation. The current projected solicitation date is TBA, and DLA reserves the right to issue the solicitation before or after the projected date. The solicitation closing date has been extended from May 6, 2024 to May 30, 2024, 3:00 PM EDT. The contract price effective date shall be no more than 60 days after award, and the contract performance date shall be 45 days (or sooner) after award.
Notice text
2 versions
Update #2 · Latest ·
The Defense Logistics Agency is here in issuing, solicitation, SPE2D224R0006 for a national requirements contract for Lubiprostone Capsules. Procurement details follow.
Lubiprostone Capsules (8 MCG & 24 MCG) 60 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov/
Interested parties should contact Keith Ryales (215-737-9199) (Keith. Ryales@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The solicitation open April 4, 2024 and will close May 6, 2024.
Update #1 ·
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Lubiprostone Capsules. Procurement details follow.
Lubiprostone Capsules (8 MCG & 24 MCG) 60 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov/
Interested parties should contact Keith Ryales (215-737-9199) (Keith. Ryales@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is TBA. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Files
| File | Type | Posted |
|---|---|---|
| Amendment SPE2D224R0006-0002.pdf | ||
| Amendment SPE2D224R0006- 0001.pdf | ||
| SPE2D2-24-R-0006 (Lubiprostone) attachment included.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Methylphenidate ER | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity